Evaluation of a multi-herb supplement for erectile dysfunction: a randomized double-blind, placebo-controlled study
Open Access
- 15 September 2012
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 12 (1) , 155
Abstract
Background: Evidence is lacking for multi-ingredient herbal supplements claiming therapeutic effect in sexual dysfunction in men. We examined the safety and efficacy of VigRX Plus (VXP) – a proprietary polyherbal preparation for improving male sexual function, in a double blind, randomized placebo-controlled, parallel groups, multi-centre study. Methods: 78 men aged 25–50 years of age; suffering from mild to moderate erectile dysfunction (ED), participated in this study. Subjects were randomized to receive VXP or placebo at a dose of two capsules twice daily for 12 weeks. The international index of erectile function (IIEF) was the primary outcome measure of efficacy. Other efficacy measures were: Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS), Serum testosterone, Semen analysis, Investigator’s Global assessment and Subjects’ opinion. Results: In subjects receiving VXP, the IIEF-Erectile Function (EF) scores improved significantly as compared to placebo. After 12 weeks of treatment, the mean (sd) IIEF-EF score at baseline increased from 16.08 (2.87) to 25.08 (4.56) in the VXP group versus 15.86 (3.24) to 16.47 (4.25) in the placebo group (P < 0.0001). Similar results were observed in each of the remaining four domains of the IIEF (orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction).There was a significant difference for VXP versus placebo comparison of mean (sd) EDITS scores of patients: 82.31(20.23) vs 36.78(22.53) and partners :(82.75(9.8) vs 18.50(9.44);P < 0.001. Thirty-five out of 39 (90%) subjects from the VXP group and one (3%) from the placebo group wished to continue with the treatment they received. Investigator’s global assessment rated VXP therapy as very good to excellent in more than 50% patients and placebo therapy as fair to good in about 25% of patients. Incidence of side effects and subject’s rating for tolerability of treatment was similar in both groups. Conclusions: VigRX Plus was well tolerated and more effective than placebo in improving sexual function in men. Trial Registration: Clinical Trial Registry India, CTRI/2009/091/000099, 31-03-2009Keywords
This publication has 51 references indexed in Scilit:
- An Initial Evaluation of the Safety, Efficacy and Purity of VigRX, an Herbal Combination Formula, for the Enhancement of Male Sexual Health~!2009-12-10~!2010-03-04~!2010-03-31~!The Open Natural Products Journal, 2010
- Assessment of health claims, content, and safety of herbal supplements containing Ginkgo bilobaFood & Nutrition Research, 2010
- Ocular Adverse Effects Associated with Systemic MedicationsDrugs, 2007
- Erectile Dysfunction—An Observable Marker of Diabetes Mellitus? A Large National Epidemiological StudyJournal of Urology, 2006
- EVIDENCE FOR CONTAMINATION OF HERBAL ERECTILE DYSFUNCTION PRODUCTS WITH PHOSPHODIESTERASE TYPE 5 INHIBITORSJournal of Urology, 2005
- Internet websites selling herbal treatments for erectile dysfunctionInternational Journal Of Impotence Research, 2004
- The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of rho-kinase and their potential role in the erectile responseInternational Journal Of Impotence Research, 2003
- A Double-Blind Crossover Study Evaluating the Efficacy of Korean Red Ginseng in Patients With Erectile Dysfunction: A Preliminary ReportJournal of Urology, 2002
- Herbal medicineWestern Journal of Medicine, 2001
- An Experimental Study of the Effect of Ginkgo Biloba Extract on the Human and Rabbit Corpus Cavernosum TissueJournal of Urology, 1996